Opportunities to fund research innovations, programs, personnel, infrastructure and equipment are available through Federal, Provincial and Agency funding opportunities. For internal opportunities visit Internal Funding.
Genomic Applications Partnership Program (GAPP)
EOI Deadline: November 13, 2017; 9am ET
Ontario Genomics is pleased to announce that Round 10 of Genome Canada’s GAPP is now open. GAPP funds public-private research collaborations focused on developing genomics-derived technologies that address opportunities and challenges identified by industry, government, not-for-profits or other “Receptors” of genomics knowledge and tools.
The program provides a unique opportunity for Receptor organizations to collaborate with an ‘omics researcher’ and to leverage R&D investments with public funding. To apply, contact Shobha Ramsubir, Senior Manager – Business Development & Research, to determine project eligibility and to obtain the Expr3ession of Interest (EOI) form.
• Budget: $300K — $6M (total)
• Co-Funding Model: 1/3 Genome Canada (max), 1/3 Receptor (min), 1/3 Other
• Award Term: 1 to 3 years
• Stage: Downstream R&D, Validation, Pilot
• Funding Recipient: Genome Canad award to academic partner only
NOTE: To better prepare applicants for this competition, Ontario Genomics will host an external panel review of EOIs in early December. All eligible applicants must be available to present in person at that time.
The Jay & Aiden Barker Breakthrough Grant in Clinical & Basic Sciences 2017
Epilepsy Canada (EC) is requesting research proposals from established researchers to conduct investigations that explore the basic mechanisms of epileptic seizures.
A widespread assortment of submissions are encourage. In particular, interest in submissions that are high risk in nature that if successful would have near term applicability in the treatment of epilepsy and hopefully lead to finding a cure.
Applications having a more clinical focus are also encouraged but they should be experimental in nature and have clear hypothesis that potentially leads to better clinical outcomes.
Please visit the Epilepsy Canada website for more details and application.